180
Participants
Start Date
October 28, 2025
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
Urolithin A
Urolithin A (UA) is a widely available dietary supplement devoid of any known sided effects that is reported to improve mitochondrial function. The UA substance used in this investigation is regulated under Generally Recognized as Safe (GRAS) by the US FDA (GRN No. 000791) (https://www.fda.gov/media/120300/download) and is being advertised and sold as an oral supplement. The daily dose (1 gram) and duration (8 weeks) have already been tested in previous clinical trials.
Placebo
The placebo will consist of methylcellulose and will appear identical to the active supplement. The placebo will be provided by the manufacturer of Urolithin A.
RECRUITING
National Institute of Aging, Clinical Research Unit, Baltimore
National Institute on Aging (NIA)
NIH